Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Oct 18, 2023

Total Value ($000): $313,225 (100.0% shares, 0.0% debt)

Holdings (6)

CNTA CENTESSA PHARMACEUTICALS PLC 41.2%

Value ($000) $129,162 Shares 19,963,157 Est. Cost $20.88 Unrealized —

PCVX VAXCYTE INC 17.1%

Value ($000) $53,524 Shares 1,049,893 Est. Cost $32.16 Unrealized +53.4%

PHAT PHATHOM PHARMACEUTICALS INC 12.5%

Value ($000) $39,000 Shares 3,760,869 Est. Cost $18.86 Unrealized -27.3%

— MERUS N V 12.0%

Value ($000) $37,728 Shares 1,600,000 Est. Cost $14.08 Unrealized —

AURA AURA BIOSCIENCES INC 8.7%

Value ($000) $27,268 Shares 3,039,892 Est. Cost $17.87 Unrealized -39.8%

NAMS NEWAMSTERDAM PHARMA COMPANY 8.5%

Value ($000) $26,543 Shares 2,869,565 Est. Cost $10.96 Unrealized -1.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$129,162	41.2%	$20.88	—	SPONSORED ADS	152309100
PCVX	VAXCYTE INC	1,049,893	$53,524	17.1%	$32.16	+53.4%	COM	92243G108
PHAT	PHATHOM PHARMACEUTICALS INC	3,760,869	$39,000	12.5%	$18.86	-27.3%	COM	71722W107
—	MERUS N V	1,600,000	$37,728	12.0%	$14.08	—	COM	N5749R100
AURA	AURA BIOSCIENCES INC	3,039,892	$27,268	8.7%	$17.87	-39.8%	COM	05153U107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$26,543	8.5%	$10.96	-1.2%	ORDINARY SHARES	N62509109